{"transactions":[{"id":1643272,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":24699,"kind":"organization","name":"Westlake BioPartners Fund I, L.P.","position":1,"cik":"0001749591","reported_name":"Westlake BioPartners Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24700,"kind":"organization","name":"Westlake BioPartners GP I, LLC","position":2,"cik":"0002007650","reported_name":"Westlake BioPartners GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24703,"kind":"organization","name":"Westlake BioPartners Opportunity Fund I, L.P.","position":3,"cik":"0001811946","reported_name":"Westlake BioPartners Opportunity Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24704,"kind":"organization","name":"Westlake BioPartners Opportunity GP I, LLC","position":4,"cik":"0001811945","reported_name":"Westlake BioPartners Opportunity GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12102,"kind":"person","name":"Harper Sean E","position":5,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Redeemable Convertible Preferred Stock","published_at":"2024-02-14T22:35:32.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":false,"shares":3349538,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held directly by Westlake BioPartners Opportunity Fund I, L.P. (\"Westlake Opportunity\"). The general partner of Westlake Opportunity is Westlake BioPartners Opportunity GP I, LLC (\"Westlake Opportunity GP I\"). The voting and dispositive control over Westlake Opportunity GP I is shared by the managing directors of Westlake Opportunity GP I, Beth Seidenberg and Sean Harper, none of whom has veto power, and each of whom disclaims beneficial ownership of the shares held by Westlake Opportunity except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":735984},"source":{"system":"sec-edgar","filing":"0001104659-24-024091","document":"tm246188-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1749591/000110465924024091/tm246188-1_4seq1.xml","form_type":"4"}},{"id":1643271,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":24699,"kind":"organization","name":"Westlake BioPartners Fund I, L.P.","position":1,"cik":"0001749591","reported_name":"Westlake BioPartners Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24700,"kind":"organization","name":"Westlake BioPartners GP I, LLC","position":2,"cik":"0002007650","reported_name":"Westlake BioPartners GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24703,"kind":"organization","name":"Westlake BioPartners Opportunity Fund I, L.P.","position":3,"cik":"0001811946","reported_name":"Westlake BioPartners Opportunity Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24704,"kind":"organization","name":"Westlake BioPartners Opportunity GP I, LLC","position":4,"cik":"0001811945","reported_name":"Westlake BioPartners Opportunity GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12102,"kind":"person","name":"Harper Sean E","position":5,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Redeemable Convertible Preferred Stock","published_at":"2024-02-14T22:35:32.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":false,"shares":4006624,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Westlake BioPartners Fund I, L.P. (\"Westlake I\"). The general partner of Westlake I is Westlake BioPartners GP I, LLC (\"Westlake GP I\"). The voting and dispositive control over Westlake GP I is shared by the managing directors of Westlake GP I, Beth Seidenberg and Sean Harper, none of whom has veto power, and each of whom disclaims beneficial ownership of the shares held by Westlake I except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":880364},"source":{"system":"sec-edgar","filing":"0001104659-24-024091","document":"tm246188-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1749591/000110465924024091/tm246188-1_4seq1.xml","form_type":"4"}},{"id":1643270,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":24699,"kind":"organization","name":"Westlake BioPartners Fund I, L.P.","position":1,"cik":"0001749591","reported_name":"Westlake BioPartners Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24700,"kind":"organization","name":"Westlake BioPartners GP I, LLC","position":2,"cik":"0002007650","reported_name":"Westlake BioPartners GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24703,"kind":"organization","name":"Westlake BioPartners Opportunity Fund I, L.P.","position":3,"cik":"0001811946","reported_name":"Westlake BioPartners Opportunity Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24704,"kind":"organization","name":"Westlake BioPartners Opportunity GP I, LLC","position":4,"cik":"0001811945","reported_name":"Westlake BioPartners Opportunity GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12102,"kind":"person","name":"Harper Sean E","position":5,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Redeemable Convertible Preferred Stock","published_at":"2024-02-14T22:35:32.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":false,"shares":8830901,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Westlake BioPartners Fund I, L.P. (\"Westlake I\"). The general partner of Westlake I is Westlake BioPartners GP I, LLC (\"Westlake GP I\"). The voting and dispositive control over Westlake GP I is shared by the managing directors of Westlake GP I, Beth Seidenberg and Sean Harper, none of whom has veto power, and each of whom disclaims beneficial ownership of the shares held by Westlake I except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1940388},"source":{"system":"sec-edgar","filing":"0001104659-24-024091","document":"tm246188-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1749591/000110465924024091/tm246188-1_4seq1.xml","form_type":"4"}},{"id":1643269,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":24699,"kind":"organization","name":"Westlake BioPartners Fund I, L.P.","position":1,"cik":"0001749591","reported_name":"Westlake BioPartners Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24700,"kind":"organization","name":"Westlake BioPartners GP I, LLC","position":2,"cik":"0002007650","reported_name":"Westlake BioPartners GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24703,"kind":"organization","name":"Westlake BioPartners Opportunity Fund I, L.P.","position":3,"cik":"0001811946","reported_name":"Westlake BioPartners Opportunity Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24704,"kind":"organization","name":"Westlake BioPartners Opportunity GP I, LLC","position":4,"cik":"0001811945","reported_name":"Westlake BioPartners Opportunity GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12102,"kind":"person","name":"Harper Sean E","position":5,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Redeemable Convertible Preferred Stock","published_at":"2024-02-14T22:35:32.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":false,"shares":4401771,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Westlake BioPartners Fund I, L.P. (\"Westlake I\"). The general partner of Westlake I is Westlake BioPartners GP I, LLC (\"Westlake GP I\"). The voting and dispositive control over Westlake GP I is shared by the managing directors of Westlake GP I, Beth Seidenberg and Sean Harper, none of whom has veto power, and each of whom disclaims beneficial ownership of the shares held by Westlake I except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":967188},"source":{"system":"sec-edgar","filing":"0001104659-24-024091","document":"tm246188-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1749591/000110465924024091/tm246188-1_4seq1.xml","form_type":"4"}},{"id":1643268,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":24699,"kind":"organization","name":"Westlake BioPartners Fund I, L.P.","position":1,"cik":"0001749591","reported_name":"Westlake BioPartners Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24700,"kind":"organization","name":"Westlake BioPartners GP I, LLC","position":2,"cik":"0002007650","reported_name":"Westlake BioPartners GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24703,"kind":"organization","name":"Westlake BioPartners Opportunity Fund I, L.P.","position":3,"cik":"0001811946","reported_name":"Westlake BioPartners Opportunity Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24704,"kind":"organization","name":"Westlake BioPartners Opportunity GP I, LLC","position":4,"cik":"0001811945","reported_name":"Westlake BioPartners Opportunity GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12102,"kind":"person","name":"Harper Sean E","position":5,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-14T22:35:32.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":true,"shares":735984,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock received upon conversion of shares of the reported series of preferred stock on a 1-for-4.5511 basis without payment of further consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's Common Stock received upon conversion of shares of the reported series of preferred stock on a 1-for-4.5511 basis without payment of further consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held directly by Westlake BioPartners Opportunity Fund I, L.P. (\"Westlake Opportunity\"). The general partner of Westlake Opportunity is Westlake BioPartners Opportunity GP I, LLC (\"Westlake Opportunity GP I\"). The voting and dispositive control over Westlake Opportunity GP I is shared by the managing directors of Westlake Opportunity GP I, Beth Seidenberg and Sean Harper, none of whom has veto power, and each of whom disclaims beneficial ownership of the shares held by Westlake Opportunity except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":735984,"source":{"system":"sec-edgar","filing":"0001104659-24-024091","document":"tm246188-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1749591/000110465924024091/tm246188-1_4seq1.xml","form_type":"4"}},{"id":1643267,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":24699,"kind":"organization","name":"Westlake BioPartners Fund I, L.P.","position":1,"cik":"0001749591","reported_name":"Westlake BioPartners Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24700,"kind":"organization","name":"Westlake BioPartners GP I, LLC","position":2,"cik":"0002007650","reported_name":"Westlake BioPartners GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24703,"kind":"organization","name":"Westlake BioPartners Opportunity Fund I, L.P.","position":3,"cik":"0001811946","reported_name":"Westlake BioPartners Opportunity Fund I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24704,"kind":"organization","name":"Westlake BioPartners Opportunity GP I, LLC","position":4,"cik":"0001811945","reported_name":"Westlake BioPartners Opportunity GP I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12102,"kind":"person","name":"Harper Sean E","position":5,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-14T22:35:32.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":true,"shares":3787940,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock received upon conversion of shares of the reported series of preferred stock on a 1-for-4.5511 basis without payment of further consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's Common Stock received upon conversion of shares of the reported series of preferred stock on a 1-for-4.5511 basis without payment of further consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Westlake BioPartners Fund I, L.P. (\"Westlake I\"). The general partner of Westlake I is Westlake BioPartners GP I, LLC (\"Westlake GP I\"). The voting and dispositive control over Westlake GP I is shared by the managing directors of Westlake GP I, Beth Seidenberg and Sean Harper, none of whom has veto power, and each of whom disclaims beneficial ownership of the shares held by Westlake I except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":3787940,"source":{"system":"sec-edgar","filing":"0001104659-24-024091","document":"tm246188-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1749591/000110465924024091/tm246188-1_4seq1.xml","form_type":"4"}},{"id":1896427,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":24701,"kind":"organization","name":"Westlake BioPartners Fund II, L.P.","position":1,"cik":"0001811947","reported_name":"Westlake BioPartners Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24702,"kind":"organization","name":"Westlake BioPartners GP II, LLC","position":2,"cik":"0001811948","reported_name":"Westlake BioPartners GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12102,"kind":"person","name":"Harper Sean E","position":3,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Redeemable Convertible Preferred Stock","published_at":"2023-05-11T21:16:01.000Z","date":"2023-05-09","kind":"exercise","planned":false,"acquired":false,"shares":2038148,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of preferred stock is convertible into one share of Common Stock and has no expiration date. Immediately prior to the completion of the IPO, all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of preferred stock is convertible into one share of Common Stock and has no expiration date. Immediately prior to the completion of the IPO, all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of preferred stock is convertible into one share of Common Stock and has no expiration date. Immediately prior to the completion of the IPO, all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of preferred stock is convertible into one share of Common Stock and has no expiration date. Immediately prior to the completion of the IPO, all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F6","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held directly by Westlake BioPartners Fund II, L.P., or Westlake Fund II. Westlake BioPartners GP II, LLC, or Westlake GP II, is the general partner of Westlake Fund II. Westlake GP II may be deemed to have sole voting and dispositive power with regard to the shares held directly by Westlake Fund II. Beth C. Seidenberg and Sean E. Harper are the Managing Directors of Westlake GP II and share voting and dispositive power over the shares held by Westlake Fund II, each of whom disclaims beneficial ownership of the shares held by Westlake Fund II except to the extent of such person's pecuniary interest therein, if any."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This report on Form 4 is jointly filed by Westlake Fund II, Westlake GP II and Sean E. Harper. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of such person's or entity's pecuniary interest therein, if any. Westlake Fund II has designated a representative, Beth C. Seidenberg, a Managing Director of Westlake GP II, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2038148},"source":{"system":"sec-edgar","filing":"0001209191-23-028886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1541946/000120919123028886/doc4.xml","form_type":"4"}},{"id":1896426,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":24701,"kind":"organization","name":"Westlake BioPartners Fund II, L.P.","position":1,"cik":"0001811947","reported_name":"Westlake BioPartners Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24702,"kind":"organization","name":"Westlake BioPartners GP II, LLC","position":2,"cik":"0001811948","reported_name":"Westlake BioPartners GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12102,"kind":"person","name":"Harper Sean E","position":3,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Redeemable Convertible Preferred Stock","published_at":"2023-05-11T21:16:01.000Z","date":"2023-05-09","kind":"exercise","planned":false,"acquired":false,"shares":2445786,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of preferred stock is convertible into one share of Common Stock and has no expiration date. Immediately prior to the completion of the IPO, all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of preferred stock is convertible into one share of Common Stock and has no expiration date. Immediately prior to the completion of the IPO, all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of preferred stock is convertible into one share of Common Stock and has no expiration date. Immediately prior to the completion of the IPO, all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of preferred stock is convertible into one share of Common Stock and has no expiration date. Immediately prior to the completion of the IPO, all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F6","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held directly by Westlake BioPartners Fund II, L.P., or Westlake Fund II. Westlake BioPartners GP II, LLC, or Westlake GP II, is the general partner of Westlake Fund II. Westlake GP II may be deemed to have sole voting and dispositive power with regard to the shares held directly by Westlake Fund II. Beth C. Seidenberg and Sean E. Harper are the Managing Directors of Westlake GP II and share voting and dispositive power over the shares held by Westlake Fund II, each of whom disclaims beneficial ownership of the shares held by Westlake Fund II except to the extent of such person's pecuniary interest therein, if any."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This report on Form 4 is jointly filed by Westlake Fund II, Westlake GP II and Sean E. Harper. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of such person's or entity's pecuniary interest therein, if any. Westlake Fund II has designated a representative, Beth C. Seidenberg, a Managing Director of Westlake GP II, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2445786},"source":{"system":"sec-edgar","filing":"0001209191-23-028886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1541946/000120919123028886/doc4.xml","form_type":"4"}},{"id":1896425,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":24701,"kind":"organization","name":"Westlake BioPartners Fund II, L.P.","position":1,"cik":"0001811947","reported_name":"Westlake BioPartners Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24702,"kind":"organization","name":"Westlake BioPartners GP II, LLC","position":2,"cik":"0001811948","reported_name":"Westlake BioPartners GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12102,"kind":"person","name":"Harper Sean E","position":3,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Redeemable Convertible Preferred Stock","published_at":"2023-05-11T21:16:01.000Z","date":"2023-05-09","kind":"exercise","planned":false,"acquired":false,"shares":4056795,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of preferred stock is convertible into one share of Common Stock and has no expiration date. Immediately prior to the completion of the IPO, all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of preferred stock is convertible into one share of Common Stock and has no expiration date. Immediately prior to the completion of the IPO, all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of preferred stock is convertible into one share of Common Stock and has no expiration date. Immediately prior to the completion of the IPO, all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of preferred stock is convertible into one share of Common Stock and has no expiration date. Immediately prior to the completion of the IPO, all shares of preferred stock automatically converted into shares of Common Stock."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F6","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held directly by Westlake BioPartners Fund II, L.P., or Westlake Fund II. Westlake BioPartners GP II, LLC, or Westlake GP II, is the general partner of Westlake Fund II. Westlake GP II may be deemed to have sole voting and dispositive power with regard to the shares held directly by Westlake Fund II. Beth C. Seidenberg and Sean E. Harper are the Managing Directors of Westlake GP II and share voting and dispositive power over the shares held by Westlake Fund II, each of whom disclaims beneficial ownership of the shares held by Westlake Fund II except to the extent of such person's pecuniary interest therein, if any."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This report on Form 4 is jointly filed by Westlake Fund II, Westlake GP II and Sean E. Harper. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of such person's or entity's pecuniary interest therein, if any. Westlake Fund II has designated a representative, Beth C. Seidenberg, a Managing Director of Westlake GP II, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4056795},"source":{"system":"sec-edgar","filing":"0001209191-23-028886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1541946/000120919123028886/doc4.xml","form_type":"4"}},{"id":1896424,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":24701,"kind":"organization","name":"Westlake BioPartners Fund II, L.P.","position":1,"cik":"0001811947","reported_name":"Westlake BioPartners Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24702,"kind":"organization","name":"Westlake BioPartners GP II, LLC","position":2,"cik":"0001811948","reported_name":"Westlake BioPartners GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12102,"kind":"person","name":"Harper Sean E","position":3,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-11T21:16:01.000Z","date":"2023-05-09","kind":"purchase","planned":false,"acquired":true,"shares":1250000,"price":18,"value":22500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares of Common Stock purchased in the Issuer's initial public offering of Common Stock (the \"IPO\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held directly by Westlake BioPartners Fund II, L.P., or Westlake Fund II. Westlake BioPartners GP II, LLC, or Westlake GP II, is the general partner of Westlake Fund II. Westlake GP II may be deemed to have sole voting and dispositive power with regard to the shares held directly by Westlake Fund II. Beth C. Seidenberg and Sean E. Harper are the Managing Directors of Westlake GP II and share voting and dispositive power over the shares held by Westlake Fund II, each of whom disclaims beneficial ownership of the shares held by Westlake Fund II except to the extent of such person's pecuniary interest therein, if any."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This report on Form 4 is jointly filed by Westlake Fund II, Westlake GP II and Sean E. Harper. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of such person's or entity's pecuniary interest therein, if any. Westlake Fund II has designated a representative, Beth C. Seidenberg, a Managing Director of Westlake GP II, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":9790729,"source":{"system":"sec-edgar","filing":"0001209191-23-028886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1541946/000120919123028886/doc4.xml","form_type":"4"}},{"id":1896423,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":24701,"kind":"organization","name":"Westlake BioPartners Fund II, L.P.","position":1,"cik":"0001811947","reported_name":"Westlake BioPartners Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24702,"kind":"organization","name":"Westlake BioPartners GP II, LLC","position":2,"cik":"0001811948","reported_name":"Westlake BioPartners GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12102,"kind":"person","name":"Harper Sean E","position":3,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-11T21:16:01.000Z","date":"2023-05-09","kind":"exercise","planned":false,"acquired":true,"shares":8540729,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock received upon conversion of shares of the reported series of preferred stock on a one-for-one basis without payment of further consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Common Stock received upon conversion of shares of the reported series of preferred stock on a one-for-one basis without payment of further consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held directly by Westlake BioPartners Fund II, L.P., or Westlake Fund II. Westlake BioPartners GP II, LLC, or Westlake GP II, is the general partner of Westlake Fund II. Westlake GP II may be deemed to have sole voting and dispositive power with regard to the shares held directly by Westlake Fund II. Beth C. Seidenberg and Sean E. Harper are the Managing Directors of Westlake GP II and share voting and dispositive power over the shares held by Westlake Fund II, each of whom disclaims beneficial ownership of the shares held by Westlake Fund II except to the extent of such person's pecuniary interest therein, if any."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This report on Form 4 is jointly filed by Westlake Fund II, Westlake GP II and Sean E. Harper. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of such person's or entity's pecuniary interest therein, if any. Westlake Fund II has designated a representative, Beth C. Seidenberg, a Managing Director of Westlake GP II, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":8540729,"source":{"system":"sec-edgar","filing":"0001209191-23-028886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1541946/000120919123028886/doc4.xml","form_type":"4"}},{"id":126869,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-07-17T00:20:07.000Z","date":"2018-07-16","kind":"sale","acquired":false,"shares":1525,"price":195.71,"value":298457.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019; 3,000 RSUs which vest in installments of 1,477 5/3/2019 and 1,523 on 5/3/2020; 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021; and 4,508 RSUs which vest in installments of 1,487 on 4/27/2020, 1,488 on 4/27/2021 and 1,533 on 4/27/2022.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 495 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":56082,"source":{"system":"sec-edgar","filing":"0001127602-18-023315","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218023315/form4.xml","form_type":"4"}},{"id":127917,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-06-12T23:07:40.000Z","date":"2018-06-12","kind":"sale","acquired":false,"shares":1525,"price":184.27,"value":281011.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019; 3,000 RSUs which vest in installments of 1,477 5/3/2019 and 1,523 on 5/3/2020; 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021; and 4,508 RSUs which vest in installments of 1,487 on 4/27/2020, 1,488 on 4/27/2021 and 1,533 on 4/27/2022.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 398 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":57510,"source":{"system":"sec-edgar","filing":"0001127602-18-020733","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218020733/form4.xml","form_type":"4"}},{"id":128929,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-05-15T23:52:09.000Z","date":"2018-05-14","kind":"sale","acquired":false,"shares":1525,"price":174.1,"value":265502.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019; 3,000 RSUs which vest in installments of 1,477 5/3/2019 and 1,523 on 5/3/2020; 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021; and 4,508 RSUs which vest in installments of 1,487 on 4/27/2020, 1,488 on 4/27/2021 and 1,533 on 4/27/2022.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 398 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":59035,"source":{"system":"sec-edgar","filing":"0001127602-18-017561","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218017561/form4.xml","form_type":"4"}},{"id":129155,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-05-07T22:58:28.000Z","date":"2018-05-03","kind":"tax_withholding","acquired":false,"shares":736,"price":169.43,"value":124700.48,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019; 3,000 RSUs which vest in installments of 1,477 5/3/2019 and 1,523 on 5/3/2020; and 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 398 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":60560,"source":{"system":"sec-edgar","filing":"0001127602-18-016535","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218016535/form4.xml","form_type":"4"}},{"id":129443,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Nqso (Right to Buy)","published_at":"2018-05-01T23:07:33.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":34702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 4/27/2020, 4/27/2021 and 4/27/2022, respectively."}],"balance_after":34702,"derivative":{"exercise_price":177.46,"exercise_date":"2020-04-27","expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":34702},"source":{"system":"sec-edgar","filing":"0001127602-18-015838","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218015838/form4.xml","form_type":"4"}},{"id":129442,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-05-01T23:07:33.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":4508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 4/27/2020, 4/27/2021 and 4/27/2022, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 477 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":61296,"source":{"system":"sec-edgar","filing":"0001127602-18-015838","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218015838/form4.xml","form_type":"4"}},{"id":129862,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-04-16T23:03:06.000Z","date":"2018-04-12","kind":"sale","acquired":false,"shares":1525,"price":172.68,"value":263337.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 477 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":56788,"source":{"system":"sec-edgar","filing":"0001127602-18-014688","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218014688/form4.xml","form_type":"4"}},{"id":130438,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-03-27T23:40:33.000Z","date":"2018-03-23","kind":"tax_withholding","acquired":false,"shares":7549,"price":176.08,"value":1329227.92,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 477 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":58313,"source":{"system":"sec-edgar","filing":"0001127602-18-012857","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218012857/form4.xml","form_type":"4"}},{"id":130660,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-03-20T00:52:04.000Z","date":"2018-03-16","kind":"sale","acquired":false,"shares":1525,"price":189.75,"value":289368.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 403 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":65682,"source":{"system":"sec-edgar","filing":"0001127602-18-012188","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218012188/form4.xml","form_type":"4"}},{"id":131008,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-03-10T00:25:30.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":15118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019, respectively; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 403 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":67207,"source":{"system":"sec-edgar","filing":"0001127602-18-011020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218011020/form4.xml","form_type":"4"}},{"id":132431,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-02-16T01:57:46.000Z","date":"2018-02-14","kind":"sale","acquired":false,"shares":1525,"price":174.18,"value":265624.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019, respectively; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 403 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":52089,"source":{"system":"sec-edgar","filing":"0001127602-18-006488","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218006488/form4.xml","form_type":"4"}},{"id":133165,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-02-02T01:35:58.000Z","date":"2018-01-31","kind":"tax_withholding","acquired":false,"shares":606,"price":191.27,"value":115909.62,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019, respectively; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 403 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":53614,"source":{"system":"sec-edgar","filing":"0001127602-18-003451","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218003451/form4.xml","form_type":"4"}},{"id":133164,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-02-02T01:35:58.000Z","date":"2018-01-30","kind":"tax_withholding","acquired":false,"shares":453,"price":198,"value":89694.0,"ownership":{"direct":true},"balance_after":54200,"source":{"system":"sec-edgar","filing":"0001127602-18-003451","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218003451/form4.xml","form_type":"4"}},{"id":133776,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2018-01-18T01:19:28.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":1525,"price":185.62,"value":283070.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 663 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":54673,"source":{"system":"sec-edgar","filing":"0001127602-18-001997","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218001997/form4.xml","form_type":"4"}},{"id":134488,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-12-13T01:24:39.000Z","date":"2017-12-12","kind":"sale","acquired":false,"shares":1525,"price":176.83,"value":269665.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1."}],"balance_after":56106,"source":{"system":"sec-edgar","filing":"0001127602-17-034510","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217034510/form4.xml","form_type":"4"}},{"id":135567,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-11-15T00:27:10.000Z","date":"2017-11-13","kind":"sale","acquired":false,"shares":1525,"price":171.58,"value":261659.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1."}],"balance_after":57631,"source":{"system":"sec-edgar","filing":"0001127602-17-032117","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217032117/form4.xml","form_type":"4"}},{"id":136554,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-10-11T00:29:28.000Z","date":"2017-10-09","kind":"sale","acquired":false,"shares":1525,"price":185.95,"value":283573.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1."}],"balance_after":59156,"source":{"system":"sec-edgar","filing":"0001127602-17-029692","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217029692/form4.xml","form_type":"4"}},{"id":140989,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Nqso (Right to Buy)","published_at":"2017-05-04T00:48:25.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":40305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively."}],"balance_after":40305,"derivative":{"exercise_price":162.6,"exercise_date":"2019-05-01","expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":40305},"source":{"system":"sec-edgar","filing":"0001127602-17-016751","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217016751/form4.xml","form_type":"4"}},{"id":140988,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-05-04T00:48:25.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":4551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 1,715 RSUs which vest on 1/31/2018; 2,640 RSUs which vest in two installments of 1,300 and 1,340 on 1/30/2018 and 1/30/2019, respectively; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,551 RSUs which vest in installments of 1,501 on 5/1/2019, 1,502 on 5/1/2029 and 1,548 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 386 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":60496,"source":{"system":"sec-edgar","filing":"0001127602-17-016751","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217016751/form4.xml","form_type":"4"}},{"id":141765,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-03-28T22:54:05.000Z","date":"2017-03-24","kind":"tax_withholding","acquired":false,"shares":12128,"price":166.04,"value":2013733.12,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,715 RSUs which vest on 1/31/2018; 2,640 RSUs which vest in two installments of 1,300 and 1,340 on 1/30/2018 and 1/30/2019, respectively; and 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 386 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":55945,"source":{"system":"sec-edgar","filing":"0001127602-17-013093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217013093/form4.xml","form_type":"4"}},{"id":142320,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-03-09T22:05:36.000Z","date":"2017-03-07","kind":"grant","acquired":true,"shares":23092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 1,715 RSUs which vest on 1/31/2018; 2,640 RSUs which vest in two installments of 1,300 and 1,340 on 1/30/2018 and 1/30/2019, respectively; and 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 328 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":67866,"source":{"system":"sec-edgar","filing":"0001127602-17-011083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217011083/form4.xml","form_type":"4"}},{"id":144288,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-02-02T23:59:18.000Z","date":"2017-01-31","kind":"tax_withholding","acquired":false,"shares":668,"price":154.43,"value":103159.24,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 1,715 RSUs which vest on 1/31/2018; 2,640 RSUs which vest in two installments of 1,300 and 1,340 on 1/30/2018 and 1/30/2019, respectively; and 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 328 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":44774,"source":{"system":"sec-edgar","filing":"0001127602-17-003738","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217003738/form4.xml","form_type":"4"}},{"id":144395,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-02-01T00:08:30.000Z","date":"2017-01-30","kind":"tax_withholding","acquired":false,"shares":513,"price":157.16,"value":80623.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 3,380 RSUs which vest in two installments of 1,665 and 1,715 on 1/31/2017 and 1/31/2018, respectively; 2,640 RSUs which vest in two installments of 1,300 and 1,340 on 1/30/2018 and 1/30/2019, respectively; and 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 438 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":45442,"source":{"system":"sec-edgar","filing":"0001127602-17-003200","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217003200/form4.xml","form_type":"4"}},{"id":144394,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2017-02-01T00:08:30.000Z","date":"2017-01-28","kind":"tax_withholding","acquired":false,"shares":1056,"price":157.16,"value":165960.96,"ownership":{"direct":true},"balance_after":45955,"source":{"system":"sec-edgar","filing":"0001127602-17-003200","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217003200/form4.xml","form_type":"4"}},{"id":153057,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Nqso (Right to Buy)","published_at":"2016-05-06T00:28:42.000Z","date":"2016-05-03","kind":"grant","acquired":true,"shares":38112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively."}],"balance_after":38112,"derivative":{"exercise_price":156.35,"exercise_date":"2018-05-03","expiration_date":"2026-05-03","underlying":"Common Stock","underlying_shares":38112},"source":{"system":"sec-edgar","filing":"0001127602-16-051290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216051290/form4.xml","form_type":"4"}},{"id":153056,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2016-05-06T00:28:42.000Z","date":"2016-05-03","kind":"grant","acquired":true,"shares":4477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 2,543 RSUs which vest on 1/28/2017; 3,380 RSUs which vest in two installments of 1,665 and 1,715 on 1/31/2017 and 1/31/2018, respectively; 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1,340 on 1/30/2019; and 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 432 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":46725,"source":{"system":"sec-edgar","filing":"0001127602-16-051290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216051290/form4.xml","form_type":"4"}},{"id":153258,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2016-05-03T23:14:21.000Z","date":"2016-04-29","kind":"sale","acquired":false,"shares":21875,"price":157.9947,"value":3456134.0625,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The price reported is an average price. The prices ranged from $156.48 to $159.51 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,543 RSUs which vest on 1/28/2017; 3,380 RSUs which vest in two installments of 1,665 and 1,715 on 1/31/2017 and 1/31/2018, respectively; and 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1,340 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 432 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":42248,"source":{"system":"sec-edgar","filing":"0000899243-16-019140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000089924316019140/doc4.xml","form_type":"4"}},{"id":153419,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2016-04-29T23:43:04.000Z","date":"2016-04-27","kind":"tax_withholding","acquired":false,"shares":1659,"price":162.85,"value":270168.15,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,543 RSUs which vest on 1/28/2017; 3,380 RSUs which vest in two installments of 1,665 and 1,715 on 1/31/2017 and 1/31/2018, respectively; and 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1,340 on 1/30/2019.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 432 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":64123,"source":{"system":"sec-edgar","filing":"0001127602-16-050336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216050336/form4.xml","form_type":"4"}},{"id":154330,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2016-03-29T21:09:57.000Z","date":"2016-03-25","kind":"tax_withholding","acquired":false,"shares":23785,"price":149.24,"value":3549673.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,943 RSUs which vest on 4/27/2016; 2,543 RSUs which vest on 1/28/2017; 3,380 RSUs which vest in two installments of 1,665 and 1,715 on 1/31/2017 and 1/31/2018, respectively; and 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1,340 on 1/30/2019.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 667 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":65782,"source":{"system":"sec-edgar","filing":"0001127602-16-047730","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216047730/form4.xml","form_type":"4"}},{"id":155071,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2016-03-04T23:12:06.000Z","date":"2016-03-02","kind":"grant","acquired":true,"shares":45268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,943 RSUs which vest on 4/27/2016; 2,543 RSUs which vest on 1/28/2017; 3,380 RSUs which vest in two installments of 1,665 and 1,715 on 1/31/2017 and 1/31/2018, respectively; and 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1,340 on 1/30/2019.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 575 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":89162,"source":{"system":"sec-edgar","filing":"0001127602-16-045127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216045127/form4.xml","form_type":"4"}},{"id":157185,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2016-02-02T01:29:04.000Z","date":"2016-01-31","kind":"tax_withholding","acquired":false,"shares":651,"price":152.73,"value":99427.23,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,943 RSUs which vest on 4/27/2016; 2,543 RSUs which vest on 1/28/2017; 3,380 RSUs which vest in two installments of 1,665 and 1,715 on 1/31/2017 and 1/31/2018, respectively; and 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1,340 on 1/30/2019.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 575 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":43894,"source":{"system":"sec-edgar","filing":"0001127602-16-038849","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216038849/form4.xml","form_type":"4"}},{"id":157184,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2016-02-02T01:29:04.000Z","date":"2016-01-28","kind":"tax_withholding","acquired":false,"shares":999,"price":150.47,"value":150319.53,"ownership":{"direct":true},"balance_after":44281,"source":{"system":"sec-edgar","filing":"0001127602-16-038849","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216038849/form4.xml","form_type":"4"}},{"id":164474,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2015-04-28T23:58:44.000Z","date":"2015-04-27","kind":"tax_withholding","acquired":false,"shares":1575,"price":167.91,"value":264458.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,943 RSUs which vest on 4/27/2016; 5,010 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively; and 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1,340 on 1/30/2019.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 517 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":45280,"source":{"system":"sec-edgar","filing":"0001127602-15-015472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215015472/form4.xml","form_type":"4"}},{"id":164473,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2015-04-28T23:58:44.000Z","date":"2015-04-25","kind":"tax_withholding","acquired":false,"shares":1065,"price":167.91,"value":178824.15,"ownership":{"direct":true},"balance_after":46855,"source":{"system":"sec-edgar","filing":"0001127602-15-015472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215015472/form4.xml","form_type":"4"}},{"id":164602,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2015-04-23T21:04:47.000Z","date":"2015-04-22","kind":"sale","acquired":false,"shares":28000,"price":171.58,"value":4804240.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price.  The prices ranged from $171.52 to $171.84 per share.  Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,040 RSUs which vest in one installment of 2,040 on 4/25/2015; 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 5,010 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively; and 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1,340 on 1/30/2019.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 677 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":47920,"source":{"system":"sec-edgar","filing":"0001127602-15-015038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215015038/form4.xml","form_type":"4"}},{"id":165311,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2015-03-31T22:47:13.000Z","date":"2015-03-27","kind":"tax_withholding","acquired":false,"shares":28624,"price":160.55,"value":4595583.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,040 RSUs which vest in one installment of 2,040 on 4/25/2015; 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 5,010 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively; and 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1,340 on 1/30/2019.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 677 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":75920,"source":{"system":"sec-edgar","filing":"0001127602-15-012981","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215012981/form4.xml","form_type":"4"}},{"id":165880,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2015-03-07T02:02:04.000Z","date":"2015-03-04","kind":"grant","acquired":true,"shares":54577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,040 RSUs which vest in one installment of 2,040 on 4/25/2015; 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 5,010 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively; and 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1,340 on 1/30/2019.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 573 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":104162,"source":{"system":"sec-edgar","filing":"0001127602-15-010544","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215010544/form4.xml","form_type":"4"}},{"id":167235,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2015-02-04T00:01:00.000Z","date":"2015-01-30","kind":"grant","acquired":true,"shares":3940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/30/2017, 1/30/2018 and 1/30/2019, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 2,040 RSUs which vest in one installment of 2,040 on 4/25/2015; 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 5,101 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively; and 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1,340 on 1/30/2019.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 573 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":49585,"source":{"system":"sec-edgar","filing":"0001127602-15-004132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215004132/form4.xml","form_type":"4"}},{"id":167405,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2015-01-30T21:56:06.000Z","date":"2015-01-28","kind":"tax_withholding","acquired":false,"shares":35,"price":158.89,"value":5561.15,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,040 RSUs which vest in one installment of 2,040 on 4/25/2015; 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 5,101 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; and 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 573 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":45645,"source":{"system":"sec-edgar","filing":"0001127602-15-003486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215003486/form4.xml","form_type":"4"}},{"id":167404,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2015-01-30T21:56:06.000Z","date":"2015-01-28","kind":"tax_withholding","acquired":false,"shares":928,"price":158.89,"value":147449.92,"ownership":{"direct":true},"balance_after":45680,"source":{"system":"sec-edgar","filing":"0001127602-15-003486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215003486/form4.xml","form_type":"4"}},{"id":168091,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2015-01-05T21:22:18.000Z","date":"2014-12-31","kind":"tax_withholding","acquired":false,"shares":13046,"price":160.63,"value":2095578.98,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,040 RSUs which vest in one installment of 2,040 on 4/25/2015; 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017; and 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 664 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":46608,"source":{"system":"sec-edgar","filing":"0001127602-15-000660","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215000660/form4.xml","form_type":"4"}},{"id":171158,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2014-08-07T20:22:56.000Z","date":"2014-08-05","kind":"sale","acquired":false,"shares":14000,"price":127.2947,"value":1782125.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price.  The prices ranged from $127.21 to $127.46 per share.  Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 25,000 RSUs which fully vest on 12/31/2014; 2,040 RSUs which vest in one installment of 2,040 on 4/25/2015; 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017; and 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 513 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":59503,"source":{"system":"sec-edgar","filing":"0001127602-14-024954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214024954/form4.xml","form_type":"4"}},{"id":174304,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2014-04-29T21:42:06.000Z","date":"2014-04-27","kind":"tax_withholding","acquired":false,"shares":56,"price":111.41,"value":6238.96,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 25,000 RSUs which fully vest on 12/31/2014; 2,040 RSUs which vest in one installment of 2,040 on 4/25/2015; 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017; and 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 417 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":73407,"source":{"system":"sec-edgar","filing":"0001127602-14-015507","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214015507/form4.xml","form_type":"4"}},{"id":174303,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2014-04-29T21:42:06.000Z","date":"2014-04-27","kind":"tax_withholding","acquired":false,"shares":1490,"price":111.41,"value":166000.9,"ownership":{"direct":true},"balance_after":73463,"source":{"system":"sec-edgar","filing":"0001127602-14-015507","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214015507/form4.xml","form_type":"4"}},{"id":174302,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2014-04-29T21:42:06.000Z","date":"2014-04-26","kind":"tax_withholding","acquired":false,"shares":601,"price":111.41,"value":66957.41,"ownership":{"direct":true},"balance_after":74953,"source":{"system":"sec-edgar","filing":"0001127602-14-015507","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214015507/form4.xml","form_type":"4"}},{"id":174301,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2014-04-29T21:42:06.000Z","date":"2014-04-25","kind":"tax_withholding","acquired":false,"shares":1034,"price":113.72,"value":117586.48,"ownership":{"direct":true},"balance_after":75554,"source":{"system":"sec-edgar","filing":"0001127602-14-015507","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214015507/form4.xml","form_type":"4"}},{"id":175144,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2014-03-18T20:26:48.000Z","date":"2014-03-14","kind":"tax_withholding","acquired":false,"shares":7683,"price":123.96,"value":952384.68,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,150 RSUs which fully vest on 4/26/2014; 25,000 RSUs which fully vest on 12/31/2014; 4,020 RSUs which vest in one installment of 1,980 on 4/25/2014 and one installment of 2,040 on 4/25/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017; and 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 523 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":76588,"source":{"system":"sec-edgar","filing":"0001127602-14-012021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214012021/form4.xml","form_type":"4"}},{"id":175447,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2014-03-07T22:29:31.000Z","date":"2014-03-05","kind":"grant","acquired":true,"shares":14724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,150 RSUs which fully vest on 4/26/2014; 25,000 RSUs which fully vest on 12/31/2014; 4,020 RSUs which vest in one installment of 1,980 on 4/25/2014 and one installment of 2,040 on 4/25/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017; and 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 415 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":84163,"source":{"system":"sec-edgar","filing":"0001127602-14-010751","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214010751/form4.xml","form_type":"4"}},{"id":176798,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2014-02-04T22:43:02.000Z","date":"2014-01-31","kind":"grant","acquired":true,"shares":5044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/31/2016, 1/31/2017 and 1/31/2018, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 1,150 RSUs which fully vest on 4/26/2014; 25,000 RSUs which fully vest on 12/31/2014; 4,020 RSUs which vest in one installment of 1,980 on 4/25/2014 and one installment of 2,040 on 4/25/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017; and 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 415 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":69439,"source":{"system":"sec-edgar","filing":"0001127602-14-004380","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214004380/form4.xml","form_type":"4"}},{"id":184586,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Nqso (Right to Buy)","published_at":"2013-05-06T21:27:56.000Z","date":"2013-05-02","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":50.44,"exercise_date":"2012-04-28","expiration_date":"2016-04-28","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001127602-13-015815","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213015815/form4.xml","form_type":"4"}},{"id":184585,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2013-05-06T21:27:56.000Z","date":"2013-05-02","kind":"sale","acquired":false,"shares":8000,"price":106.3237,"value":850589.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price.  The prices ranged from $106.30 to $106.35 per share.  Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,150 RSUs which fully vest on 4/26/2014; 25,000 RSUs which fully vest on 12/31/2014; 4,020 RSUs which vest in one installment of 1,980 on 4/25/2014 and one installment of 2,040 on 4/25/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 200 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":64180,"source":{"system":"sec-edgar","filing":"0001127602-13-015815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213015815/form4.xml","form_type":"4"}},{"id":184584,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2013-05-06T21:27:56.000Z","date":"2013-05-02","kind":"exercise","acquired":true,"shares":8000,"price":50.44,"value":403520.0,"ownership":{"direct":true},"balance_after":72180,"source":{"system":"sec-edgar","filing":"0001127602-13-015815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213015815/form4.xml","form_type":"4"}},{"id":184995,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2013-04-30T21:18:02.000Z","date":"2013-04-28","kind":"tax_withholding","acquired":false,"shares":588,"price":108.38,"value":63727.44,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,150 RSUs which fully vest on 4/26/2014; 25,000 RSUs which fully vest on 12/31/2014; 4,020 RSUs which vest in one installment of 1,980 on 4/25/2014 and one installment of 2,040 on 4/25/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 200 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":64180,"source":{"system":"sec-edgar","filing":"0001127602-13-014771","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213014771/form4.xml","form_type":"4"}},{"id":184994,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2013-04-30T21:18:02.000Z","date":"2013-04-26","kind":"tax_withholding","acquired":false,"shares":601,"price":108.66,"value":65304.66,"ownership":{"direct":true},"balance_after":64768,"source":{"system":"sec-edgar","filing":"0001127602-13-014771","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213014771/form4.xml","form_type":"4"}},{"id":185020,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2013-04-29T22:04:07.000Z","date":"2013-04-25","kind":"tax_withholding","acquired":false,"shares":1034,"price":104.93,"value":108497.62,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,125 RSUs which fully vest on 4/28/2013; 2,300 RSUs which vest in two equal annual installments of 1,150 each commencing 4/26/2013; 25,000 RSUs which fully vest on 12/31/2014; 4,020 RSUs which vest in one installment of 1,980 on 4/25/2014 and one installment of 2,040 on 4/25/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 200 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":65369,"source":{"system":"sec-edgar","filing":"0001127602-13-014707","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213014707/form4.xml","form_type":"4"}},{"id":185867,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2013-03-19T23:43:41.000Z","date":"2013-03-15","kind":"tax_withholding","acquired":false,"shares":6918,"price":92.18,"value":637701.24,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,125 RSUs which fully vest on 4/28/2013; 2,300 RSUs which vest in two equal annual installments of 1,150 each commencing 4/26/2013; 25,000 RSUs which fully vest on 12/31/2014; 6,000 RSUs which vest in two equal installments of 1,980 each on 4/25/2013 and 4/25/2014 and one installment of 2,040 on 4/25/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 200 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":66403,"source":{"system":"sec-edgar","filing":"0001127602-13-011474","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213011474/form4.xml","form_type":"4"}},{"id":186148,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2013-03-08T23:35:18.000Z","date":"2013-03-06","kind":"grant","acquired":true,"shares":13257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,125 RSUs which fully vest on 4/28/2013; 2,300 RSUs which vest in two equal annual installments of 1,150 each commencing 4/26/2013; 25,000 RSUs which fully vest on 12/31/2014; 6,000 RSUs which vest in two equal installments of 1,980 each on 4/25/2013 and 4/25/2014 and one installment of 2,040 on 4/25/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 117 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":73238,"source":{"system":"sec-edgar","filing":"0001127602-13-010169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213010169/form4.xml","form_type":"4"}},{"id":187731,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2013-01-31T01:20:35.000Z","date":"2013-01-28","kind":"grant","acquired":true,"shares":7477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/28/2015, 1/28/2016 and 1/28/2017, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 1,125 RSUs which fully vest on 4/28/2013; 2,300 RSUs which vest in two equal annual installments of 1,150 each commencing 4/26/2013; 25,000 RSUs which fully vest on 12/31/2014; 6,000 RSUs which vest in two equal installments of 1,980 each on 4/25/2013 and 4/25/2014 and one installment of 2,040 on 4/25/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 117 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":59981,"source":{"system":"sec-edgar","filing":"0001127602-13-003266","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760213003266/form4.xml","form_type":"4"}},{"id":192125,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Nqso (Right to Buy)","published_at":"2012-07-31T23:35:39.000Z","date":"2012-07-27","kind":"exercise","acquired":false,"shares":14400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":69.78,"exercise_date":"2008-02-08","expiration_date":"2014-02-08","underlying":"Common Stock","underlying_shares":14400},"source":{"system":"sec-edgar","filing":"0001127602-12-023278","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212023278/form4.xml","form_type":"4"}},{"id":192124,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Nqso (Right to Buy)","published_at":"2012-07-31T23:35:39.000Z","date":"2012-07-27","kind":"exercise","acquired":false,"shares":16109,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":71.88,"exercise_date":"2007-04-03","expiration_date":"2013-04-03","underlying":"Common Stock","underlying_shares":16109},"source":{"system":"sec-edgar","filing":"0001127602-12-023278","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212023278/form4.xml","form_type":"4"}},{"id":192123,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Nqso (Right to Buy)","published_at":"2012-07-31T23:35:39.000Z","date":"2012-07-27","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16000,"derivative":{"exercise_price":58.43,"exercise_date":"2012-04-26","expiration_date":"2020-04-26","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001127602-12-023278","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212023278/form4.xml","form_type":"4"}},{"id":192122,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Iso (Right to Buy)","published_at":"2012-07-31T23:35:39.000Z","date":"2012-07-27","kind":"exercise","acquired":false,"shares":1391,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":71.88,"exercise_date":"2010-04-03","expiration_date":"2013-04-03","underlying":"Common Stock","underlying_shares":1391},"source":{"system":"sec-edgar","filing":"0001127602-12-023278","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212023278/form4.xml","form_type":"4"}},{"id":192121,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-07-31T23:35:39.000Z","date":"2012-07-27","kind":"sale","acquired":false,"shares":39900,"price":82.333,"value":3285086.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price.  The prices ranged from $82.28 to $82.48 per share.  Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,125 RSUs which fully vest on 4/28/2013; 2,300 RSUs which vest in two equal annual installments of 1,150 each commencing 4/26/2013; 25,000 RSUs which fully vest on 12/31/2014; 6,000 RSUs which vest in two equal installments of 1,980 each on 4/25/2013 and 4/25/2014 and one installment of 2,040 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":52432,"source":{"system":"sec-edgar","filing":"0001127602-12-023278","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212023278/form4.xml","form_type":"4"}},{"id":192120,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-07-31T23:35:39.000Z","date":"2012-07-27","kind":"exercise","acquired":true,"shares":14400,"price":69.78,"value":1004832.0,"ownership":{"direct":true},"balance_after":84332,"source":{"system":"sec-edgar","filing":"0001127602-12-023278","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212023278/form4.xml","form_type":"4"}},{"id":192119,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-07-31T23:35:39.000Z","date":"2012-07-27","kind":"exercise","acquired":true,"shares":16109,"price":71.88,"value":1157914.92,"ownership":{"direct":true},"balance_after":69932,"source":{"system":"sec-edgar","filing":"0001127602-12-023278","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212023278/form4.xml","form_type":"4"}},{"id":192118,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-07-31T23:35:39.000Z","date":"2012-07-27","kind":"exercise","acquired":true,"shares":8000,"price":58.43,"value":467440.0,"ownership":{"direct":true},"balance_after":61823,"source":{"system":"sec-edgar","filing":"0001127602-12-023278","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212023278/form4.xml","form_type":"4"}},{"id":192117,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-07-31T23:35:39.000Z","date":"2012-07-27","kind":"exercise","acquired":true,"shares":1391,"price":71.88,"value":99985.08,"ownership":{"direct":true},"balance_after":53823,"source":{"system":"sec-edgar","filing":"0001127602-12-023278","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212023278/form4.xml","form_type":"4"}},{"id":193886,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Nqso (Right to Buy)","published_at":"2012-05-04T01:13:02.000Z","date":"2012-05-03","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":50.44,"exercise_date":"2012-04-28","expiration_date":"2016-04-28","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001127602-12-015861","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212015861/form4.xml","form_type":"4"}},{"id":193885,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Nqso (Right to Buy)","published_at":"2012-05-04T01:13:02.000Z","date":"2012-05-03","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":42.13,"exercise_date":"2012-04-29","expiration_date":"2015-04-29","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001127602-12-015861","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212015861/form4.xml","form_type":"4"}},{"id":193884,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-05-04T01:13:02.000Z","date":"2012-05-03","kind":"tax_withholding","acquired":false,"shares":6758,"price":71.17,"value":480966.86,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,125 RSUs which fully vest on 4/28/2013; 2,300 RSUs which vest in two equal annual installments of 1,150 each commencing 4/26/2013; 25,000 RSUs which fully vest on 12/31/2014; 6,000 RSUs which vest in two equal installments of 1,980 each on 4/25/2013 and 4/25/2014 and one installment of 2,040 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":52387,"source":{"system":"sec-edgar","filing":"0001127602-12-015861","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212015861/form4.xml","form_type":"4"}},{"id":193883,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-05-04T01:13:02.000Z","date":"2012-05-03","kind":"tax_withholding","acquired":false,"shares":4695,"price":71.17,"value":334143.15,"ownership":{"direct":true},"balance_after":59145,"source":{"system":"sec-edgar","filing":"0001127602-12-015861","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212015861/form4.xml","form_type":"4"}},{"id":193882,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-05-04T01:13:02.000Z","date":"2012-05-03","kind":"exercise","acquired":true,"shares":8000,"price":50.44,"value":403520.0,"ownership":{"direct":true},"balance_after":63840,"source":{"system":"sec-edgar","filing":"0001127602-12-015861","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212015861/form4.xml","form_type":"4"}},{"id":193881,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-05-04T01:13:02.000Z","date":"2012-05-03","kind":"exercise","acquired":true,"shares":6000,"price":42.13,"value":252780.0,"ownership":{"direct":true},"balance_after":55840,"source":{"system":"sec-edgar","filing":"0001127602-12-015861","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212015861/form4.xml","form_type":"4"}},{"id":194002,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-05-02T00:51:32.000Z","date":"2012-04-29","kind":"tax_withholding","acquired":false,"shares":2545,"price":71.64,"value":182323.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 1,125 RSUs which fully vest on 4/28/2013; 2,300 RSUs which vest in two equal annual installments of 1,150 each commencing 4/26/2013; 25,000 RSUs which fully vest on 12/31/2014; 6,000 RSUs which vest in two equal installments of 1,980 each on 4/25/2013 and 4/25/2014 and one installment of 2,040 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":49840,"source":{"system":"sec-edgar","filing":"0001127602-12-015251","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212015251/form4.xml","form_type":"4"}},{"id":194001,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-05-02T00:51:32.000Z","date":"2012-04-28","kind":"tax_withholding","acquired":false,"shares":526,"price":71.64,"value":37682.64,"ownership":{"direct":true},"balance_after":52385,"source":{"system":"sec-edgar","filing":"0001127602-12-015251","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212015251/form4.xml","form_type":"4"}},{"id":194000,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-05-02T00:51:32.000Z","date":"2012-04-27","kind":"grant","acquired":true,"shares":8654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively."}],"balance_after":52911,"source":{"system":"sec-edgar","filing":"0001127602-12-015251","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212015251/form4.xml","form_type":"4"}},{"id":194083,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-04-30T21:12:09.000Z","date":"2012-04-26","kind":"tax_withholding","acquired":false,"shares":514,"price":70.19,"value":36077.66,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,450 RSUs which fully vest on 4/29/2012; 2,250 RSUs which vest in two equal annual installments of 1,125 each commencing 4/28/2012; 2,300 RSUs which vest in two equal annual installments of 1,150 each commencing on 4/26/2013; 25,000 RSUs which fully vest on 12/31/2014; and 6,000 RSUs which vest in two equal installments of 1,980 each on 4/25/2013 and 4/25/2014 and one installment of 2,040 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":44257,"source":{"system":"sec-edgar","filing":"0001127602-12-014950","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212014950/form4.xml","form_type":"4"}},{"id":194761,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-03-20T21:50:10.000Z","date":"2012-03-16","kind":"tax_withholding","acquired":false,"shares":1519,"price":68.26,"value":103686.94,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,450 RSUs which fully vest on 4/29/2012; 2,250 RSUs which vest in two equal annual installments of 1,125 each commencing 4/28/2012; 3,450 RSUs which vest in three equal annual installments of 1,150 each commencing 4/26/2012; 25,000 RSUs which fully vest on 12/31/2014; and 6,000 RSUs which vest in two equal installments of 1,980 each on 4/25/2013 and 4/25/2014 and one installment of 2,040 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis"}],"balance_after":44771,"source":{"system":"sec-edgar","filing":"0001127602-12-011448","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212011448/form4.xml","form_type":"4"}},{"id":194866,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":12102,"kind":"person","name":"Harper Sean E","position":1,"cik":"0001541946","reported_name":"Harper Sean E","relationship":{"officer":true,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2012-03-15T23:54:32.000Z","date":"2012-03-14","kind":"grant","acquired":true,"shares":4140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,450 RSUs which fully vest on 4/29/2012; 2,250 RSUs which vest in two equal annual installments of 1,125 each commencing 4/28/2012; 3,450 RSUs which vest in three equal annual installments of 1,150 each commencing 4/26/2012; 25,000 RSUs which fully vest on 12/31/2014; and 6,000 RSUs which vest in two equal installments of 1,980 each on 4/25/2013 and 4/25/2014 and one installment of 2,040 on 4/25/2015.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":46290,"source":{"system":"sec-edgar","filing":"0001127602-12-010815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760212010815/form4.xml","form_type":"4"}}]}